Thursday, June 22, 14:00 - 17:00

About Laetitia Szaller | General Counsel, VP Business Development, Corporate Secretary at AM-Pharma

Laetitia has over 20 years’ experience in multiple sectors, including 15 in the pharmaceuticals and medical device industry, leading and managing complex multi-jurisdiction operations including global multi-million M&A deals, licensing and collaboration partnerships. Prior to joining AM-Pharma in April 2020 as General Counsel, VP Business Development and Corporate Secretary, she was at UCB as global Associate General Counsel BD, M&A and Antitrust. 

Prior to UCB, Laetitia was Legal Director, Emerging Markets EMEA, Central European Region and  Benelux at Zoetis (Pfizer former   animal   health   division), and has also led the EMEA legal department  for the Abbott Vascular division at Abbott. She also held global positions at the Carlson Rezidor Hotel Group and at the automotive division (Wabco) at American Standard.  Laetitia is a qualified lawyer in both the UK and Belgium, with extensive international experience, regularly speaking at various legal conferences.

About AM-Pharma

AM-Pharma’s purpose is to save the lives of patients confronted with sepsis, kidney disease and organ injury. Our initial focus is sepsis-associated acute kidney injury, the cause of death for hundreds of thousands of people hospitalized each year. Our proprietary recombinant human alkaline phosphatase has the potential to become the first treatment for sepsis-associated acute kidney injury and is about to be evaluated in a global pivotal Phase III clinical trial. We are a dedicated team driven to bring treatment options to severely ill patients, their families and acute care professionals.

Powered by:
BCF Courses BV   

    Connect with us                  

Join BioBusiness Summer School

Privacy Policy
Terms & Conditions 

Chamber of Commerce: 75874415


© Copyright 2020 by BCF Courses